| Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of Myelofibrosis (NCT03373877) | Samus Therapeutics, Inc. | 2018-05-24 |
| Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus (NCT02995005) | Johns Hopkins Bloomberg School of Public Health | 2018-05-24 |
| A Study to Determine the Relative Bioavailability of Two New Relacorilant Capsule Variants (NCT03540836) | Corcept Therapeutics | 2018-05-24 |
| Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas (NCT03489343) | Symphogen A/S | 2018-05-24 |
| PK Study of Single-Dose ZTI-01 in Children (<12 Years of Age) (NCT03709914) | Nabriva Therapeutics AG | 2018-05-24 |
| Gene-by-Stress Interactions in Intervention Studies Significance (NCT03011645) | Duke University | 2018-05-24 |
| A Study of PCSK9 Inhibitor AK102 in Healthy Subjects (NCT04169386) | Akeso | 2018-05-23 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of CC-99677 in Healthy Adult Subjects (NCT03554993) | Celgene | 2018-05-23 |
| BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma (NCT03502577) | Fred Hutchinson Cancer Center | 2018-05-23 |
| A Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic Castration-resistant Prostate Cancer (NCT03514836) | SOTIO a.s. | 2018-05-23 |
| Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum Chemotherapy (NCT03558139) | Gilead Sciences | 2018-05-23 |
| A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy (NCT03542175) | Memorial Sloan Kettering Cancer Center | 2018-05-23 |
| CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects (NCT03713892) | Chong Kun Dang Pharmaceutical | 2018-05-23 |
| 68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa) (NCT03490032) | Advanced Accelerator Applications | 2018-05-23 |
| Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-911 in Healthy Subjects (NCT03551288) | Suven Life Sciences Limited | 2018-05-22 |
| A Phase I/II Study of XZP-3287 in Metastasis Solid Tumors (NCT04539496) | Sihuan Pharmaceutical Holdings Group Ltd. | 2018-05-22 |
| EGFR-IL12-CART Cells for Patients With Metastatic Colorectal Cancer (NCT03542799) | Shenzhen Second People's Hospital | 2018-05-22 |
| Lintuzumab-Ac225 in Combination with Cladribine + Cytarabine + Filgastrim + Mitoxantrone (CLAG-M) for Relapsed/Refractory Acute Myeloid Leukemia (NCT03441048) | Medical College of Wisconsin | 2018-05-22 |
| Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors (NCT03510104) | Meryx, Inc. | 2018-05-22 |
| MTX110 by Convection-Enhanced Delivery in Treating Participants With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma (NCT03566199) | Sabine Mueller, MD, PhD | 2018-05-22 |
| Assessment of Safety and Efficacy of IM19 for Relapsed or Refractory NHL Patients (NCT03528421) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2018-05-22 |
| Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid Arthritis (NCT03410056) | Amgen | 2018-05-22 |
| Study to Investigate the Pharmacokinetics & Safety Following One Application of 3 Different Doses 0.5,0.75,& 1.25 gm,a Transdermal Estradiol Cream (VML-0203), in Comparison to a Single Dose of EstroGel 1.25 gm to Healthy Post-menopausal Women. (NCT03556800) | Viramal Limited | 2018-05-22 |
| Study of Pioglitazone in Sporadic Inclusion Body Myositis (NCT03440034) | Johns Hopkins University | 2018-05-22 |
| Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 (NCT02890758) | Brenda Cooper, MD | 2018-05-22 |
| A Trial of CXD101 in Combination With Nivolumab in Patients With Metastatic Microsatellite-Stable Colorectal Cancer (NCT03993626) | Celleron Therapeutics Ltd. | 2018-05-22 |
| Study to Detect Oral Administration of Budesonide in Women. (NCT03537326) | Parc de Salut Mar | 2018-05-22 |
| Accessing Mobility Using Wearable Sensors (NCT04306588) | Baylor College of Medicine | 2018-05-21 |
| NY-ESO-1-specific T Cell Receptor (TCR) T Cell in Sarcoma (NCT03462316) | Sun Yat-sen University | 2018-05-21 |
| Walnuts to Achieve Lasting NUTrition to Prevent Diabetes (NCT03334175) | University of California, San Francisco | 2018-05-21 |
| Comparative Safety, Tolerability, Pharmacokinetic Study of AVT02 (100MG/ML) and Humira (100MG/ML) in Healthy Volunteers (NCT03579823) | Alvotech Swiss AG | 2018-05-21 |
| Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Antitumor Activity of KN046 in Subjects With Advanced Solid Tumors (NCT03529526) | Alphamab (Australia) Co Pty Ltd. | 2018-05-21 |
| A Study to Evaluate Safety and PK Profiles of OLX10010 in Healthy Subjects (NCT03569267) | Olix Pharmaceuticals, Inc. | 2018-05-21 |
| Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors (NCT03490669) | AstraZeneca | 2018-05-21 |
| Feasibility and Acceptability of a Physical Activity Behavior Change Intervention for Parkinson's Disease (NCT03696589) | Teachers College, Columbia University | 2018-05-21 |
| Pevonedistat and Low Dose Cytarabine in Adult Patients With AML and MDS (NCT03459859) | Justin Watts, MD | 2018-05-21 |
| [11C]Yohimbine PET Study of alpha2-AR (NCT03520543) | Hospices Civils de Lyon | 2018-05-21 |
| Study of Roflumilast in Combination With Standard Chemotherapy for High-risk Diffuse Large B-cell Lymphoma (NCT03458546) | The University of Texas Health Science Center at San Antonio | 2018-05-21 |
| Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers (NCT03564340) | Regeneron Pharmaceuticals | 2018-05-21 |
| A First-in-Human Study of alpha1H in Patients With Non-muscle Invasive Bladder Cancer (NCT03560479) | Hamlet Pharma AB | 2018-05-21 |
| Safety, Tolerability and PK/PD of JMT103 in Patients With Bone Metastases From Tumors (NCT03550508) | Shanghai JMT-Bio Inc. | 2018-05-21 |
| A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel)(R) With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed Adults (NCT03110757) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-05-20 |
| International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia (NCT03705507) | University of Birmingham | 2018-05-18 |
| Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer (NCT03480152) | National Cancer Institute (NCI) | 2018-05-18 |
| A Study to Evaluate the Mass Balance of 14C-Napabucasin in Healthy Adult Male Subjects (NCT03525405) | Sumitomo Pharma America, Inc. | 2018-05-18 |
| Safety and Dose-Finding Study of DTX401 (AAV8G6PC) in Adults With Glycogen Storage Disease Type Ia (GSDIa) (NCT03517085) | Ultragenyx Pharmaceutical Inc | 2018-05-18 |
| Topical Preparation of Pomegranate and Ginkgo Biloba for Anti-aging Activities (NCT03772418) | Ahmed A. H. Abdellatif | 2018-05-18 |
| To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB) (NCT03472287) | Castle Creek Pharmaceuticals, LLC | 2018-05-18 |
| A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME) (NCT03511898) | ThromboGenics | 2018-05-18 |
| Bioequivalence Study Between Levocetirizine Oral Disintegrating Tablet (ODT) and Levocetirizine Immediate Release Tablet (IRT) (NCT03555890) | GlaxoSmithKline | 2018-05-18 |
| A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia(AML) (NCT04827069) | Sunshine Lake Pharma Co., Ltd. | 2018-05-18 |
| Study to Evaluate the QT / QTc Interval Prolongation Potential of Vericiguat (NCT03504982) | Bayer | 2018-05-17 |
| M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas (NCT03451773) | National Cancer Institute (NCI) | 2018-05-17 |
| A Safety, Tolerability, Pharmacokinetics (PK) and Target Engagement (TE) Study of GSK3858279 in Healthy Participants and Evaluation of the Efficacy of Repeat Doses in Participants With Osteoarthritis (OA) (NCT03485365) | GlaxoSmithKline | 2018-05-17 |
| Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer (NCT03430518) | Amy Tiersten | 2018-05-17 |
| Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT03522584) | University of Washington | 2018-05-17 |
| Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer (NCT03081858) | Lipac Oncology LLC | 2018-05-17 |
| Transcutaneous Vagus Nerve Stimulation for Motor Recovery After Stroke (NCT03292159) | Massachusetts General Hospital | 2018-05-17 |
| AGuIX Gadolinium-based Nanoparticles in Combination With Chemoradiation and Brachytherapy (NCT03308604) | Gustave Roussy, Cancer Campus, Grand Paris | 2018-05-17 |
| Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B (NCT04357600) | PT. Prodia Stem Cell Indonesia | 2018-05-17 |
| Single Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of BDM-2 in Healthy Male Subjects. (NCT03634085) | Hivih | 2018-05-17 |
| Effect of Tepotinib on the PK of the P-gp Substrate Dabigatran Etexilate (NCT03492437) | Merck KGaA, Darmstadt, Germany | 2018-05-17 |
| Safety Study and Preliminary Efficacy of Infusion Haploidentical Mesenchymal Stem Cells Derived From Bone Marrow for Treating Recessive Dystrophic Epidermolysis Bullosa (NCT04153630) | Instituto de Investigación Hospital Universitario La Paz | 2018-05-17 |
| Glasdegib Renal Impairment Study (NCT03596567) | Pfizer | 2018-05-17 |
| Ready to Use Therapeutic Food (RUTF) to Promote Growth in Cystic Fibrosis (NCT03462056) | Washington University School of Medicine | 2018-05-17 |
| The Role of Ruxolitinib in Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Neoplasm (NCT03558607) | Seoul National University Hospital | 2018-05-17 |
| Therapeutic Effect of Cassia Seed in Obesity of Patients With Schizophrenia (NCT04252131) | Calo Psychiatric Center | 2018-05-17 |
| Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-EBOMAB092-00-AB (MAb114), Administered Intravenously to Healthy Adults (NCT03478891) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-05-16 |
| A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours. (NCT03553108) | AstraZeneca | 2018-05-16 |
| A Safety and Tolerability Study of UBX0101 in Patients With Osteoarthritis of the Knee (NCT03513016) | Unity Biotechnology, Inc. | 2018-05-16 |
| A Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy Adults (NCT03473002) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-05-16 |
| Controlled Comparison of a Traditional Dressing Versus a Biologic Dressing Composed of Fetal Fibroblasts and Keratinocytes in Association With a Collagen Matrix on Skin Donor Sites (NCT03334656) | Nantes University Hospital | 2018-05-16 |
| Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery (NCT03510208) | Stanford University | 2018-05-16 |
| A Study of TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation (NCT02686372) | Lion TCR Pte. Ltd. | 2018-05-16 |
| PF-04995274 and Emotional Processing in Un-medicated Depression (NCT03516604) | University of Oxford | 2018-05-16 |
| A Study of Prexasertib (LY2606368), CHK1 Inhibitor, and LY3300054, PD-L1 Inhibitor, in Patients With Advanced Solid Tumors (NCT03495323) | Dana-Farber Cancer Institute | 2018-05-16 |
| Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation (NCT03207958) | Washington University School of Medicine | 2018-05-16 |
| Study of Dapansutrile Capsules in Heart Failure (NCT03534297) | Olatec Therapeutics, Inc. | 2018-05-16 |
| A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL (NCT03571568) | BioInvent International AB | 2018-05-16 |
| Rivastigmine BA Trial With Multiple Application of Transdermal Patches, Adaptation and Tapering Phase (NCT03573050) | SocraTec R&D GmbH | 2018-05-16 |
| Detection of Graft Versus Host Disease With [18F]F-AraG (NCT03367962) | CellSight Technologies, Inc. | 2018-05-15 |
| A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis (NCT03521232) | Entero Therapeutics | 2018-05-15 |
| Pharmacokinetic Study of LY03003 in Patients With Parkinson's Disease (NCT03589066) | Luye Pharma Group Ltd. | 2018-05-15 |
| Anti-CTLA-4 Antibody Followed by Anti-PD-1 Antibody in Recurrent or Metastatic NSCLC (NCT03527251) | Sun Yat-sen University | 2018-05-15 |
| Reduction of Zygomatic Arch in Zygomaticomaxillary Fractures (NCT04218058) | Alexandria University | 2018-05-15 |
| Analysis of the Impact of Cholecystectomy on Gut Microbiome in Adults (NCT03836170) | Shanghai Jiao Tong University School of Medicine | 2018-05-15 |
| A Study of DSP-2033 (Alvocidib) in Patients With Acute Myeloid Leukemia (NCT03563560) | Sumitomo Pharma Co., Ltd. | 2018-05-15 |
| A Study to Assess the Safety and Tolerability of Single and Multiple Ascending Doses of Oral RO7020531 in Chinese Healthy Participants. (NCT03530917) | Hoffmann-La Roche | 2018-05-15 |
| Reversing Epigenetic & Other Markers of Senescence by Transfusing Young Plasma To Older Human Subjects (NCT03353597) | Chandra Duggirala | 2018-05-15 |
| Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma (NCT03473756) | Bayer | 2018-05-15 |
| Effects of Probiotic on Inflammation and Microbiota in Patients With NASH (NCT03511365) | Northwell Health | 2018-05-15 |
| Role of Antibiotics Post Tonsillectomy (NCT03491085) | Assiut University | 2018-05-15 |
| A Study of DSP-0337 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile (NCT03416816) | Sumitomo Pharma America, Inc. | 2018-05-15 |
| Follow up Study 5-6 Years After ILIT With 2 Concomitant Allergens, Birch and Grass (NCT04296474) | Lars Olaf Cardell | 2018-05-15 |
| A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma (NCT03530683) | Pfizer | 2018-05-14 |
| Effect of a Proton Pump Inhibitor on the PK of Tepotinib (NCT03531762) | Merck KGaA, Darmstadt, Germany | 2018-05-14 |
| MTBVAC Study in Adults With and Without Latent Tuberculosis Infection in South Africa (NCT02933281) | International AIDS Vaccine Initiative | 2018-05-14 |
| Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients With Locally Advanced Hepatocellular Carcinoma (HCC) (NCT03299946) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-05-14 |
| Safety, Immunogenicity, and Protective Efficacy of Two Regimens of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Natural Transmission Season in Healthy African Adults in Mali (NCT03510481) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-05-14 |
| CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL (NCT03467256) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2018-05-14 |